publications

 

June 11, 2018
Directly bactericidal anti-Escherichia coli antibody

Szijártó et al. Trends in Microbiology

March 17, 2018
Anti-bacterial monoclonal antibodies

Nagy et al. Advances in Experimental Medicine and Biology, volume 1053

December 15, 2015
Both clades of the epidemic KPC-producing Klebsiella pneumoniae clone ST258 share a modified galactan O-antigen type

Szijártó et al. International Journal of Medical Microbiology

October 7, 2014
Alpha-hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia

Stulik et al. American Journal of Respiratory and Critical Care Medicine

June 13, 2012
Anti-bacterial monoclonal antibodies: Back to the future?

Oleksiewicz et al. Archives of Biochemistry and Biophysics

Posters

June 10, 2018
Adaptation of the human-specific S. aureus leukocidin, LukGH, to rabbit, by protein engineering

Trstenjak et al. Poster presentation at ASM Microbe 2018 (June 7-11; Atlanta, GA). Poster 145.

April 21, 2018
Functional characterization of highly potent human monoclonal antibodies targeting different antigenic sites of the pre-fusion RSV-F protein

Rouha et al. Poster presentation at ECCMID 2018. (April 21-24; Madrid, Spain). Poster P0021.

March 18, 2018
Efficacy and pharmacokinetics of cytotoxin neutralizing monoclonal antibodies in prophylactic and therapeutic rabbit models of Staphylococcus aureus pneumonia

Stulik et al. Poster presentation at GRC 2018 – Biology of Acute Respiratory Infections (March 18-23; Ventura, CA).

October 8, 2017
Population pharmacokinetic model for intravenous ASN100 in healthy subjects

Van Wart et al. Poster presentation at IDWeek 2017 (October 4-8; San Diego, CA). Poster 1849.

October 8, 2017
Serum and lung pharmacokinetics of ASN100, a monoclonal antibody combination for the prevention and treatment of Staphylococcus aureus pneumonia

Magyarics et al. Poster presentation at IDWeek 2017 (October 4-8; San Diego, CA).  Poster 1025.

September 8, 2017
Prophylactic efficacy and pharmacokinetics of cytotoxin-neutralizing monoclonal IgGs in rabbit models of Staphylococcus aureus pneumonia

Stulik et al. Poster presentation at the 2017 ASM/ESCMID Conference (September 6-8; Boston, MA). Poster 99.

September 8, 2017
Potentiating antibiotics with cytotoxin-neutralizing monoclonal antibodies in lethal murine and rabbit models of Staphylococcus aureus pneumonia

Stulik et al. Poster presentation at the 2017 ASM/ESCMID Conference (September 6-8; Boston, MA). Poster 102.

April 22, 2017
Synergistic inhibition of the concerted action of six Staphylococcus aureus cytotoxins with ASN100, a combination of two human monoclonal antibodies

Rouha et al. Poster presentation at ECCMID 2017 (April 22-25; Vienna, Austria). Poster P0470.

April 22, 2017
Efficacy of ASN100, a combination of two human monoclonal antibodies neutralizing six Staphylococcus aureus cytotoxins, in a CA-MRSA rabbit necrotizing pneumonia model

Stulik et al. Poster presentation at ECCMID 2017 (April 22-25; Vienna, Austria). Poster P0469.

October 26, 2016
Staphylococcus aureus colonized patients receiving mechanical ventilation progress to pneumonia despite antibiotic treatment

Kabak et al. Poster presentation at IDWeek 2016 (October 26-30; New Orleans, LA). Poster 1258.